PLPBP mutations cause variable phenotypes of developmental and epileptic encephalopathy
Open Access
- 1 November 2018
- journal article
- research article
- Published by Wiley in Epilepsia Open
- Vol. 3 (4) , 495-502
Abstract
Summary: Objective: Vitamin B6–dependent epilepsies are treatable disorders caused by variants in several genes, such as ALDH7A1, PNPO, and others. Recently, biallelic variants in PLPBP, formerly known as PROSC, were identified as a novel cause of vitamin B6–dependent epilepsies. Our objective was to further delineate the phenotype of PLPBP mutation.Methods: We identified 4 unrelated patients harboring a total of 4 variants in PLPBP, including 3 novel variants, in a cohort of 700 patients with developmental and epileptic encephalopathies. Clinical information in each case was collected.Results: Each patient had a different clinical course of epilepsy, with seizure onset from the first day of life to 3 months of age. Generalized tonic–clonic seizures were commonly noted. Myoclonic seizures or focal seizures were also observed in 2 patients. Interictal electroencephalography showed variable findings, such as suppression burst, focal or multifocal discharges, and diffuse slow activity. Unlike previous reports, all the patients had some degree of intellectual disability, although some of them had received early treatment with vitamin B6, suggesting that different mutation types influence the severity and outcome of the seizures.Significance: PLPBP variants should be regarded as among the causative genes of developmental and epileptic encephalopathy, even when it occurs after the neonatal period. Early diagnosis and proper treatment with pyridoxine or pyridoxal phosphate is essential to improve the neurologic prognosis in neonates or young children with poorly controlled seizures.Keywords
Funding Information
- Japan Agency for Medical Research and Development (27280301, JP17ek0109168)
- Ministry of Education, Culture, Sports, Science and Technology (24118007)
- Japan Society for the Promotion of Science (17H01539, 25293085, 25293235, 16K09975, 26670505, 26860816)
- Japan Science and Technology Corporation (11105305)
- Takeda Science Foundation
This publication has 16 references indexed in Scilit:
- An atypical case of SPG56/CYP2U1-related spastic paraplegia presenting with delayed myelinationJournal of Human Genetics, 2017
- Confirmation of mutations in PROSC as a novel cause of vitamin B 6 -dependent epilepsyJournal of Medical Genetics, 2017
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and TerminologyEpilepsia, 2017
- PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorderJournal of Human Genetics, 2017
- Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent EpilepsyThe American Journal of Human Genetics, 2016
- Treatable newborn and infant seizures due to inborn errors of metabolismEpileptic Disorders, 2015
- Enzyme-Replacement Therapy in Life-Threatening HypophosphatasiaNew England Journal of Medicine, 2012
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Neonatal vitamin-responsive epileptic encephalopathies.2010
- Pyridoxal Phosphate De-activation by Pyrroline-5-carboxylic AcidJournal of Biological Chemistry, 2001